{"transactions":[{"id":971186,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":71649,"kind":"person","name":"Fair Richard A.","position":1,"cik":"0001695851","reported_name":"Fair Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-12T23:31:31.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":875000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option will vest on December 11, 2026 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":875000,"derivative":{"exercise_price":18.77,"expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":875000},"source":{"system":"sec-edgar","filing":"0001695851-25-000004","document":"form4-12122025_111226.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000169585125000004/form4-12122025_111226.xml","form_type":"4"}},{"id":2183784,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":71649,"kind":"person","name":"Fair Richard A.","position":1,"cik":"0001695851","reported_name":"Fair Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-08-16T17:04:29.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":400000,"price":1.44,"value":576000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3rd) of the shares subject to the option will vest on the one-year anniversary on August 16, 2023, and the remaining shares will vest in twenty-four (24) equal monthly installments thereafter."}],"balance_after":400000,"derivative":{"exercise_price":1.44,"expiration_date":"2032-08-15","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001628280-22-023030","document":"wf-form4_166068384429200.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000162828022023030/wf-form4_166068384429200.xml","form_type":"4"}},{"id":2597476,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":71649,"kind":"person","name":"Fair Richard A.","position":1,"cik":"0001695851","reported_name":"Fair Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-18T12:21:16.000Z","date":"2021-08-16","kind":"grant","acquired":true,"shares":265000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This amendment is being filed to correct the typographical error in the exercise price of the stock option on the original Form 4 filed with the SEC on August 16, 2021"}],"balance_after":265000,"derivative":{"exercise_price":2.88,"exercise_date":"2022-08-16","expiration_date":"2031-08-16","underlying":"Common Stock","underlying_shares":265000},"source":{"system":"sec-edgar","filing":"0001628280-21-017225","document":"wf-form4a_162930366124028.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000162828021017225/wf-form4a_162930366124028.xml","form_type":"4/A","original_submission_date":"2021-08-16"}},{"id":2601973,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":71649,"kind":"person","name":"Fair Richard A.","position":1,"cik":"0001695851","reported_name":"Fair Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-16T16:21:08.000Z","date":"2021-08-16","kind":"grant","acquired":true,"shares":265000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of the shares subject to the stock option vest and become exercisable on December 15, 2021, and the remaining shares subject to the stock option vest and become exercisable in 12 equal monthly installments thereafter."}],"balance_after":265000,"derivative":{"exercise_price":2.91,"expiration_date":"2031-08-16","underlying":"Common Stock","underlying_shares":265000},"source":{"system":"sec-edgar","filing":"0001628280-21-017115","document":"wf-form4_162914521751992.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000162828021017115/wf-form4_162914521751992.xml","form_type":"4"}},{"id":2671806,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":71649,"kind":"person","name":"Fair Richard A.","position":1,"cik":"0001695851","reported_name":"Fair Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-11T20:48:39.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":42223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on the one-year anniversary of the date of grant."}],"balance_after":42223,"derivative":{"exercise_price":5.97,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":42223},"source":{"system":"sec-edgar","filing":"0000899243-21-023392","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321023392/doc4.xml","form_type":"4"}},{"id":2942042,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":71649,"kind":"person","name":"Fair Richard A.","position":1,"cik":"0001695851","reported_name":"Fair Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-16T13:54:52.000Z","date":"2020-12-15","kind":"grant","acquired":true,"shares":286000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of the shares subject to the stock option vest and become exercisable on December 15, 2021, and the remaining shares subject to the stock option vest and become exercisable in 12 equal monthly installments thereafter."}],"balance_after":286000,"derivative":{"exercise_price":2.97,"expiration_date":"2030-12-14","underlying":"Common Stock","underlying_shares":286000},"source":{"system":"sec-edgar","filing":"0001628280-20-017550","document":"wf-form4_160814487996152.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000162828020017550/wf-form4_160814487996152.xml","form_type":"4"}},{"id":3118623,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":71649,"kind":"person","name":"Fair Richard A.","position":1,"cik":"0001695851","reported_name":"Fair Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-08T20:30:34.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":40138,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable on  the twelve (12) month anniversary of the date of grant."}],"balance_after":40138,"derivative":{"exercise_price":6.48,"expiration_date":"2030-06-04","underlying":"Common Stock","underlying_shares":40138},"source":{"system":"sec-edgar","filing":"0000899243-20-015705","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924320015705/doc4.xml","form_type":"4"}},{"id":3200324,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":71649,"kind":"person","name":"Fair Richard A.","position":1,"cik":"0001695851","reported_name":"Fair Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-03-19T12:48:46.000Z","date":"2020-03-17","kind":"purchase","acquired":true,"shares":5000,"price":3.9997,"value":19998.5,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.97 to $4.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001628280-20-003793","document":"wf-form4_158463650892986.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000162828020003793/wf-form4_158463650892986.xml","form_type":"4"}},{"id":3290820,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":71649,"kind":"person","name":"Fair Richard A.","position":1,"cik":"0001695851","reported_name":"Fair Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-04T14:24:12.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":1257000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option vest and become exercisable on February 3, 2021, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":1257000,"derivative":{"exercise_price":1.36,"expiration_date":"2030-02-02","underlying":"Common Stock","underlying_shares":1257000},"source":{"system":"sec-edgar","filing":"0001628280-20-000991","document":"wf-form4_158084423487343.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000162828020000991/wf-form4_158084423487343.xml","form_type":"4"}},{"id":3417233,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":71649,"kind":"person","name":"Fair Richard A.","position":1,"cik":"0001695851","reported_name":"Fair Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-09-11T19:01:59.000Z","date":"2019-09-10","kind":"purchase","acquired":true,"shares":40000,"price":1.25,"value":50000.0,"ownership":{"direct":true},"balance_after":66561,"source":{"system":"sec-edgar","filing":"0001209191-19-049227","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000120919119049227/doc4.xml","form_type":"4"}},{"id":3429979,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":71649,"kind":"person","name":"Fair Richard A.","position":1,"cik":"0001695851","reported_name":"Fair Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-23T16:03:58.000Z","date":"2019-08-21","kind":"purchase","acquired":true,"shares":20000,"price":0.989,"value":19780.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $0.9855 to $0.995, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 6,561 shares acquired by the reporting person under the Issuer's 2014 Employee Stock Purchase Plan."}],"balance_after":26561,"source":{"system":"sec-edgar","filing":"0001358403-19-000111","document":"wf-form4_156659062257120.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000135840319000111/wf-form4_156659062257120.xml","form_type":"4"}},{"id":3493818,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":71649,"kind":"person","name":"Fair Richard A.","position":1,"cik":"0001695851","reported_name":"Fair Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-06-11T16:58:03.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option vest and become exercisable on January 1, 2020, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":300000,"derivative":{"exercise_price":1.87,"expiration_date":"2029-06-10","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001358403-19-000080","document":"wf-form4_156028666800640.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000135840319000080/wf-form4_156028666800640.xml","form_type":"4"}},{"id":3497110,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":71649,"kind":"person","name":"Fair Richard A.","position":1,"cik":"0001695851","reported_name":"Fair Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-07T16:45:37.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":28882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth (1/12) of the shares subject to the option shall vest on each of the first twelve (12) monthly anniversaries of the date of grant."}],"balance_after":28882,"derivative":{"exercise_price":14.66,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":28882},"source":{"system":"sec-edgar","filing":"0000899243-19-016034","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924319016034/doc4.xml","form_type":"4"}},{"id":3673745,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":71649,"kind":"person","name":"Fair Richard A.","position":1,"cik":"0001695851","reported_name":"Fair Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-05T16:10:16.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option vest and become exercisable on January 1, 2020, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":300000,"derivative":{"exercise_price":3.35,"expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001358403-19-000021","document":"wf-form4_154940100228022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000135840319000021/wf-form4_154940100228022.xml","form_type":"4"}},{"id":3791010,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":71649,"kind":"person","name":"Fair Richard A.","position":1,"cik":"0001695851","reported_name":"Fair Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-10-15T21:53:47.000Z","date":"2018-10-11","kind":"grant","acquired":true,"shares":25848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3) of the shares subject to the option shall vest on each of the first three (3) annual anniversaries of the date of grant."}],"balance_after":25848,"derivative":{"exercise_price":27.92,"expiration_date":"2028-10-11","underlying":"Common Stock","underlying_shares":25848},"source":{"system":"sec-edgar","filing":"0000899243-18-026752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924318026752/doc4.xml","form_type":"4"}},{"id":3872356,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":71649,"kind":"person","name":"Fair Richard A.","position":1,"cik":"0001695851","reported_name":"Fair Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-07-05T16:02:32.000Z","date":"2018-07-02","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option vest and become exercisable on January 2, 2019, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":225000,"derivative":{"exercise_price":7.72,"expiration_date":"2028-07-01","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001358403-18-000073","document":"wf-form4_153082093661689.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000135840318000073/wf-form4_153082093661689.xml","form_type":"4"}},{"id":4106856,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":71649,"kind":"person","name":"Fair Richard A.","position":1,"cik":"0001695851","reported_name":"Fair Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-01-04T16:03:13.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option vest and become exercisable on January 2, 2019, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":225000,"derivative":{"exercise_price":9.23,"expiration_date":"2028-01-01","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001358403-18-000010","document":"wf-form4_151509977904246.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000135840318000010/wf-form4_151509977904246.xml","form_type":"4"}},{"id":4473211,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":71649,"kind":"person","name":"Fair Richard A.","position":1,"cik":"0001695851","reported_name":"Fair Richard A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-02-01T16:11:48.000Z","date":"2017-01-30","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option vest and become exercisable on January 30, 2018, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":500000,"derivative":{"exercise_price":11.87,"expiration_date":"2027-01-29","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001358403-17-000030","document":"wf-form4_148598349482649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358403/000135840317000030/wf-form4_148598349482649.xml","form_type":"4"}}]}